ARS Pharmaceuticals
SPRY
SPRY
150 hedge funds and large institutions have $928M invested in ARS Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 58 increasing their positions, 23 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
150
Holders Change
+35
Holders Change %
+30.43%
% of All Funds
2.17%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
48
Increased
58
Reduced
23
Closed
12
Calls
$14.2M
Puts
$9.25M
Net Calls
+$4.98M
Net Calls Change
-$13.4M
Top Buyers
| 1 |
WP
1
Woodline Partners
San Francisco,
California
|
$14.3M |
| 2 |
FTM
2
First Turn Management
Del Mar,
California
|
$8.6M |
| 3 |
DFO
3
Duquesne Family Office
New York
|
$7.79M |
| 4 |
4
Morgan Stanley
New York
|
$9.26M |
| 5 |
5
Millennium Management
New York
|
$7.06M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
RCMNY
151
Rubric Capital Management (New York)
New York
| – | -$5.44M | -639,203 | Closed |
|
|
SCM
152
Sio Capital Management
New York
| – | -$1.85M | -217,864 | Closed |
|
153
Walleye Capital
New York
| – | -$608K | -71,499 | Closed |
|
|
APP
154
Avantax Planning Partners
Dubuque,
Iowa
| – | -$274K | -32,174 | Closed |
|
|
SSA
155
Schonfeld Strategic Advisors
New York
| – | -$231K | -27,139 | Closed |
|
156
Los Angeles Capital Management
Los Angeles,
California
| – | -$231K | -27,120 | Closed |
|
|
AGM
157
Alpine Global Management
New York
| – | -$199K | -23,435 | Closed |
|
158
Arrowstreet Capital
Boston,
Massachusetts
| – | -$127K | -14,967 | Closed |
|
159
Voloridge Investment Management
Jupiter,
Florida
| – | -$88.4K | -10,388 | Closed |
|
160
Principal Financial Group
Des Moines,
Iowa
| – | -$87.1K | -10,230 | Closed |
|
161
Pacer Advisors
Malvern,
Pennsylvania
| – | -$4.13K | -485 | Closed |
|